The Development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

  1. Gang Ye
  2. Joseph Gallant
  3. Jian Zheng
  4. Christopher Massey
  5. Ke Shi
  6. Wanbo Tai
  7. Abby Odle
  8. Molly Vickers
  9. Jian Shang
  10. Yushun Wan
  11. Lanying Du Dr.
  12. Hideki Aihara
  13. Stanley Perlman
  14. Aaron LeBeau  Is a corresponding author
  15. Fang Li  Is a corresponding author
  1. University of Minnesota, United States
  2. University of Iowa, United States
  3. University of Texas Medical Branch, United States
  4. Lindsley F Kimball Research Institute, United States
  5. Lindsley F Kimball Research Institute, New York Blood Center, United States

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Preprint posted
  5. Received

Download links

Share this article

https://doi.org/10.7554/eLife.64815